Laminacauda expers

Enhanced Protection for Manufacturing Highly Potent Pharmaceuticals Introduced at New Jersey Facility

Retrieved on: 
Thursday, December 7, 2023

The new equipment is the first capsule filling solution in North America to provide enhanced protection of employees and the environment from highly potent pharmaceutical products.

Key Points: 
  • The new equipment is the first capsule filling solution in North America to provide enhanced protection of employees and the environment from highly potent pharmaceutical products.
  • Many active pharmaceutical ingredients, including spray dried powders and inhalation products, are highly potent and require manufacturers to provide a permanent physical barrier to protect operators from the material.
  • “Engineering controls offer a more advanced employee protection solution in the pharmaceutical manufacturing environment,” said Justin Lacombe , Ph.D., chief scientific officer of Experic.
  • “Combined with the advanced Harro Höfliger filling technology, Experic has a complete solution for manufacturing highly potent drug products, complementing our specialized pharmaceutical spray drying and DPI development and manufacturing services.”

Pharmaceutical Contract Packaging Market to Reach US$12 Billion by 2033, Driven by Innovations in Drug Packaging | Future Market Insights, Inc.

Retrieved on: 
Thursday, October 26, 2023

NEWARK, Del., Oct. 26, 2023 /PRNewswire/ -- By the end of the year 2022, the net worth of the pharmaceutical contract packaging market was reported to have reached US$ 5.6 billion. As per our market analysis, the worldwide demand for pharmaceutical contract packaging could expand at an average of 7.5% from 2023 to 2033. By 2033, the adoption of pharmaceutical contract packaging is projected to be worth around US$ 11.9 billion, growing from US$ 6.1 billion in 2023.

Key Points: 
  • Pharmaceutical Contract Packaging Market Report: Segmentation by Packaging, Containers, and Closures, Growth Opportunities, and Revenue Forecast, 2023-2033
    NEWARK, Del., Oct. 26, 2023 /PRNewswire/ -- By the end of the year 2022, the net worth of the pharmaceutical contract packaging market was reported to have reached US$ 5.6 billion.
  • As per our market analysis, the worldwide demand for pharmaceutical contract packaging could expand at an average of 7.5% from 2023 to 2033.
  • By 2033, the adoption of pharmaceutical contract packaging is projected to be worth around US$ 11.9 billion, growing from US$ 6.1 billion in 2023.
  • The global market for pharmaceutical contract packaging services is highly fragmented and competitive due to several global and local operators.

Pharmaceutical Contract Packaging Market to Reach US$12 Billion by 2033, Driven by Innovations in Drug Packaging | Future Market Insights, Inc.

Retrieved on: 
Thursday, October 26, 2023

NEWARK, Del., Oct. 26, 2023 /PRNewswire/ -- By the end of the year 2022, the net worth of the pharmaceutical contract packaging market was reported to have reached US$ 5.6 billion. As per our market analysis, the worldwide demand for pharmaceutical contract packaging could expand at an average of 7.5% from 2023 to 2033. By 2033, the adoption of pharmaceutical contract packaging is projected to be worth around US$ 11.9 billion, growing from US$ 6.1 billion in 2023.

Key Points: 
  • Pharmaceutical Contract Packaging Market Report: Segmentation by Packaging, Containers, and Closures, Growth Opportunities, and Revenue Forecast, 2023-2033
    NEWARK, Del., Oct. 26, 2023 /PRNewswire/ -- By the end of the year 2022, the net worth of the pharmaceutical contract packaging market was reported to have reached US$ 5.6 billion.
  • As per our market analysis, the worldwide demand for pharmaceutical contract packaging could expand at an average of 7.5% from 2023 to 2033.
  • By 2033, the adoption of pharmaceutical contract packaging is projected to be worth around US$ 11.9 billion, growing from US$ 6.1 billion in 2023.
  • The global market for pharmaceutical contract packaging services is highly fragmented and competitive due to several global and local operators.

Experic Raises Additional Capital in Series B Extension to Support Additional Analytical Laboratory and Spray Drying Investments

Retrieved on: 
Thursday, October 5, 2023

Experic , a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of a Series B extension round of financing.

Key Points: 
  • Experic , a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of a Series B extension round of financing.
  • The additional capital is earmarked to support the company's double-digit organic growth and strategic investments in key operational assets.
  • The funds from this round will be allocated towards additional investments in the company’s previously announced analytical laboratory and spray drying capabilities , which are critical to enhancing Experic's manufacturing capabilities.
  • David Wood , CEO and chairman of Experic, commented on the development, “The additional funding from seasoned life science investors in this round will enable us to expand technical capabilities and accelerate growth.

Experity Announces Appointment of Adrian Agostini as Chief Revenue Officer

Retrieved on: 
Wednesday, September 6, 2023

Experity , the national leader in on-demand healthcare solutions, announced the appointment of Adrian Agostini as the company’s Chief Revenue Officer (CRO), a strategic addition to Experity’s executive leadership team.

Key Points: 
  • Experity , the national leader in on-demand healthcare solutions, announced the appointment of Adrian Agostini as the company’s Chief Revenue Officer (CRO), a strategic addition to Experity’s executive leadership team.
  • As CRO, Agostini will enable Experity to take its go-to-market strategy to the next level, creating new opportunities to unify client-facing aspects of the business into a singular organizational identity.
  • In this capacity, Agostini will take on leadership of sales, marketing, revenue operations, revenue enablement, client success, software support and implementation departments at Experity.
  • “I’m excited to begin this next chapter of my career with Experity and to build upon the company’s strong market presence within the urgent care industry,” said Agostini.

Experity Announces Call For 2024 Limelight Award Nominations

Retrieved on: 
Thursday, August 31, 2023

Experity, the national leader in on-demand healthcare solutions, is now accepting nominations for the third annual Industry Limelight Awards, which will be presented during the 2024 Urgent Care Connect Conference, hosted by Experity, taking place on February 13 –14, 2024 at the Fairmont Austin in Austin, Texas.

Key Points: 
  • Experity, the national leader in on-demand healthcare solutions, is now accepting nominations for the third annual Industry Limelight Awards, which will be presented during the 2024 Urgent Care Connect Conference, hosted by Experity, taking place on February 13 –14, 2024 at the Fairmont Austin in Austin, Texas.
  • Urgent care professionals are encouraged to submit nominations for their peers between now and October 27, 2023.
  • Experity will award one winner across three categories:
    Leadership Award - Nominate the urgent care leader that inspired clinic staff to excellence during a year of change.
  • Nominations for the 2024 Industry Limelight Awards are open now through October 27, 2023 at https://www.experityhealth.com/limelight-awards/ .

Experity Acquires OnePACS, the Leader in Teleradiology PACS

Retrieved on: 
Monday, August 14, 2023

Experity , the national leader in on-demand healthcare solutions, has acquired OnePACS, a SaaS PACS (Picture Archiving and Communication Systems) platform purpose-built for teleradiology.

Key Points: 
  • Experity , the national leader in on-demand healthcare solutions, has acquired OnePACS, a SaaS PACS (Picture Archiving and Communication Systems) platform purpose-built for teleradiology.
  • With the addition of OnePACS, the leading teleradiology PACS platform, Experity extends its position as the leading urgent care teleradiology company.
  • In addition, this merger enables Experity Teleradiology to offer a fully tech-enabled service offering.
  • Their offering is a natural complement to OnePACS' role in the teleradiology ecosystem, and their focus on urgent care dovetails well with OnePACS' teleradiology sweet spot.

Experity Celebrates Successful Investment Cycle with Employee Trip to Orlando

Retrieved on: 
Wednesday, June 14, 2023

Dr. and Mrs. Stern hosted the trip to celebrate a successful transaction in 2022, when Experity took a large investment from GTCR, with Warburg Pincus retaining a significant stake in the company.

Key Points: 
  • Dr. and Mrs. Stern hosted the trip to celebrate a successful transaction in 2022, when Experity took a large investment from GTCR, with Warburg Pincus retaining a significant stake in the company.
  • Any employee who worked at Experity at the time of the transaction was eligible to bring their family on the “Excellent Adventure” celebration.
  • “Kelly and I are beyond grateful for the dedicated, enthusiastic employees that have made Experity a success,” said Dr. Stern, CEO, Experity.
  • At Experity I feel valued as an employee and person and cannot wait to see where we go from here.

Experic Adds Spray Drying Capabilities to Enhance Pharmaceutical Formulation and Development Services

Retrieved on: 
Tuesday, May 16, 2023

Experic , a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the addition of spray drying capabilities to support the formulation and development of biopharmaceuticals.

Key Points: 
  • Experic , a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the addition of spray drying capabilities to support the formulation and development of biopharmaceuticals.
  • The new spray drying services will be available from its facility located in Cranbury, New Jersey.
  • Spray drying is an important pharmaceutical formulation technology to control powder particle size and morphology, enhance aqueous solubility of amorphous formulations to improve drug bioavailability, and engineer particles for delivery to the lungs (DPI).
  • “Spray drying is a key addition to our technology toolbox given the increasing customer demand for particle engineering services,” said Justin Lacombe , Ph.D., chief scientific officer at Experic.

EY Announces Dr. David Stern of Experity as an Entrepreneur Of The Year® 2023 Midwest Award Finalist

Retrieved on: 
Tuesday, May 16, 2023

Ernst & Young LLP (EY US) announced that Dr. David Stern , CEO of Experity , was named an Entrepreneur Of The Year® 2023 Midwest Award finalist.

Key Points: 
  • Ernst & Young LLP (EY US) announced that Dr. David Stern , CEO of Experity , was named an Entrepreneur Of The Year® 2023 Midwest Award finalist.
  • Dr. Stern was selected by an independent panel of judges.
  • “It is an honor to be recognized as a finalist for the Entrepreneur of The Year® 2023 Award alongside some of the world’s most transformational leaders,” said Dr. David Stern.
  • The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year™ Award in June 2024.